Phase behaviour is manipulated during the hydrogenation of aqueous levulinic acid in supercritical CO(2) to separate almost pure gamma-valerolactone from water and unreacted acid with reduced energy requirements compared to conventional processing.
No takes yet. Share an insight, caveat, or question.
Bourne et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: